Latest stories on KAPA
Nuclear Startup Kairos Raises $643 Million for Tennessee Project
Bloomberg63 · neutralgeneral
Kairos Pharma Reports Strong Interim Results for ENV-105 Combo
TipRanks73 · bullishproduct/pr
Kairos Pharma announces interim efficacy data from Phase 2 trial of ENV-105
The Fly63 · neutralproduct/pr
Kairos Pharma, LTD. (KAPA) files 8-K
SEC 8-K50 · neutralgeneral
Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA
StockTitan55 · neutralgeneral
Firstsource Recognized Among the Best in 'Services Eating Software' at the 2026 HFS SaS Awards
PR Newswire63 · neutralproduct/pr
Kairos Algo Outlines Rules for Stock Selection and Market Exposure
Business Insider55 · neutralgeneral
Kairos Pharma, LTD. (KAPA) files 8-K
SEC 8-K50 · neutralgeneral
Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Kairos Pharma announces 1-for-7 reverse stock split to maintain NYSE compliance
Seeking Alpha25 · bearishgeneral
Kairos Pharma, LTD. (KAPA) files 8-K
SEC 8-K50 · neutralgeneral
Kairos Pharma Announces 1-for-7 Reverse Stock Split
StockTitan25 · bearishgeneral
Kairos Pharma, LTD. (KAPA) files 8-K
SEC 8-K50 · neutralgeneral
Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
StockTitan67 · bullishproduct/pr
Is GPGI, Inc. (GPGI) A Good Stock To Buy Now?
Yahoo Finance57 · neutralanalyst
Kairos Pharma, LTD. (KAPA) files 8-K
SEC 8-K50 · neutralgeneral
Kairos Meridian Launches an Independent, Shorter Path From Problem to Impact
PR Newswire55 · neutralproduct/pr
Katana Capital Updates Daily On-Market Share Buy-Back
TipRanks71 · bullishgeneral